U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Emergency Preparedness | Drugs
  4. Bioterrorism and Drug Preparedness
  5. Products Approved for Anthrax
  1. Bioterrorism and Drug Preparedness

Products Approved for Anthrax

Image
anthrax viewed through a microscope

Anthim (obiltoxaximab) injection, for intravenous use

Anthrasil [Anthrax Immune Globulin Intravenous (Human)], sterile solution for infusion (CBER)

Biothrax (Anthrax Vaccine Adsorbed) (CBER)

Ciprofloxacin

Cyfendus (FDA approved 7/20/2023)

Doxycycline and Other Tetracyclines

Levofloxacin

Penicillin G Potassium

Penicillin G Procaine

Penicillin G Sodium

Raxibacumab

Considerations in Pediatrics, Pregnancy, and Lactation

Amoxicillin

Product Development Guidance

Back to Top